Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the methodological trade-offs between large, simple mega-trials and smaller, highly controlled mini-trials in clinical research.
of majorfeatures that distinguish two classes of clinical trials Mega-trial Mini-trial Large population (> 10 000) Small population (< 3000) Large number of clinical sites Limited number of sites (4-30) Minimal data collected/patient Maximal data collected/patient Protocol algorithm simple Algorithm more complex Entry criteria wide Entry criteria more restricted Cannot control ancillary care, treatment Complete protocolisation of care possible Data not quality assured Full quality assurance of data Cannot assess advanced technology or avant-garde or high risk therapy Can assess any technology or therapy Cannot probe the mechanism of therapy (reductionist)
No takes yet. Share an insight, caveat, or question.
Topol et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: